tirzepatide for weight management austin Loss Clinic in Pennsylvania | Mounjaro Doctor in Philly Tirzepatide is FDA-approved for weight

Mounjaro is FDA-approved for managing type 2 diabetes, but it is also commonly prescribed for weight loss in qualified patients

GLP-1 dosage schedules are intended to increase doses gradually to help balance their benefits and potential side effects

Adjusting the timing or, where possible, the dose can sometimes help

The team found that compared to seven other anti-diabetic drugs, semaglutide helped significantly lower the risk for Alzheimer's disease, including other types of GLP-1s

Tirzepatide activates two: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide)

If you are pregnant: Ozempic (semaglutide) should not be used during pregnancy